Legal Representation
Attorney
A. Tally Eitan
USPTO Deadlines
Next Deadline
663 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-05-25)
Due Date
May 25, 2027
Grace Period Ends
November 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
39 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 30, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Jun 9, 2022 | INNA | R | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | Loading... |
Feb 9, 2022 | INPR | P | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | Loading... |
Oct 4, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Sep 11, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
Sep 11, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Aug 25, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Jun 10, 2021 | LIME | I | LIMITATION FROM THE IB EXAMINED AND ENTERED | Loading... |
Jun 9, 2021 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
Jun 9, 2021 | COC. | O | CORRECTION UNDER SECTION 7 - PROCESSED | Loading... |
Jun 9, 2021 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
May 25, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Apr 23, 2021 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
Mar 22, 2021 | LIMN | I | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | Loading... |
Mar 15, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
Mar 9, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 9, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 28, 2021 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
Feb 24, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
Feb 24, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Feb 17, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 2, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Feb 2, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 2, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 2, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Feb 2, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 2, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
Feb 1, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Feb 1, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 1, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jan 24, 2021 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Dec 30, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Dec 29, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Dec 15, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Dec 15, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Dec 14, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Dec 11, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Dec 11, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Dec 10, 2020 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals, namely, pharmaceutical preparations for use in preventing and treating conditions, diseases, or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems; pharmaceutical preparations for use in prevention and treatment of allergies or allergic responses, metabolic disorders, psychiatric and emotional disorders, infection and infectious diseases, pain; drug delivery kits comprising dressings for medical, surgical, and veterinary use [ ; drug delivery agents, namely, transdermal patches sold with medication for use in the treatment of conditions, diseases or disorders of the central nervous, neurological, cardiovascular, endocrine, gastric or gastroenteric, hematologic, immunologic, inflammatory, osteologic, or respiratory systems ]
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical devices for delivery of medicated and pharmaceutical preparations, namely, implantable drug delivery pumps, drug delivery catheters, drug delivery patches sold without medication, subcutaneous drug delivery pumps, subcutaneous drug delivery patch pumps, refillable drug delivery pumps, and infusion drug delivery pumps; drug delivery device sold empty, namely, syringes, infusion drug delivery pumps; infusion sets; electromagnetic drug delivery apparatus for medical use; medical apparatus, namely, implantable ports; medical apparatus, namely, infusion and injection devices for administering drugs; medical apparatus and medical instruments for administering fluid, drugs, and nutrition, namely, infusion pumps, patch pumps being adherable subcutaneous drug delivery pumps, wearable medication injectors, wearable subcutaneous drug delivery pumps, and handheld medication injectors; medical syringes; medical devices in the nature of infusion pumps for drug infusion and for monitoring the infusion of drugs with integrated recorded software for transmission and receiving of drug infusion data, data related to the infusion pumps, drug infusion monitoring, filling and emptying of drug vials, and patient's behavior and reaction to drugs, sold as a unit therewith; drug delivery devices, namely, catheters, injection pen needles, injection needles, injection syringes and implantable subcutaneous drug delivery pumps; lancets; medical lancing devices for delivering medication, sold empty; drug eluting stents; bio-absorbable stents; synthetic stent grafts; medical diagnostic apparatus used to detect and measure the level of substances in body fluids; medical apparatus for measuring dosages and delivering pharmaceuticals, namely, infusion drug delivery pumps, subcutaneous drug delivery wearable pumps, subcutaneous drug delivery patch pumps, implantable drug delivery pumps and injection pens; electromedical rehabilitative and pain management products for clinical and home use, namely, electrical nerve and muscle stimulators, ultrasonic stimulators, magnet therapy stimulators and laser therapy stimulators; electronickinetic transdermal drug delivery control unit for the treatment of diseases
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Other
In the statement, " International Class 5 " is corrected per the restriction and the fnote dated 5/25/2021
Classification
International Classes
005
010